Cargando…
Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy
In the era of immunotherapy, there lacks of a reliable genomic predictor to identify optimal patient populations in combined radiotherapy and immunotherapy (CRI). The purpose of this study is to investigate whether genomic scores defining radiosensitivity are associated with immune response. Genomic...
Autores principales: | Dai, Yang-Hong, Wang, Ying-Fu, Shen, Po-Chien, Lo, Cheng-Hsiang, Yang, Jen-Fu, Lin, Chun-Shu, Chao, Hsing-Lung, Huang, Wen-Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172905/ https://www.ncbi.nlm.nih.gov/pubmed/34078917 http://dx.doi.org/10.1038/s41525-021-00200-0 |
Ejemplares similares
-
Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis
por: Yang, Jen-Fu, et al.
Publicado: (2019) -
Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2017) -
Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast Cancer
por: Dai, Yang-Hong, et al.
Publicado: (2021) -
Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy
por: Yang, Jen-Fu, et al.
Publicado: (2016) -
Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
por: Hsiang, Chih-Weim, et al.
Publicado: (2021)